| 摘要 |
The compound diflunisal (5-(2,4-difluorophenyl)-salicylic acid) of formula (I) is used for the production of a pharmaceutical composition for treatment of inflammatory and/or autoimmune diseases, such as psoriasis, Crohn's disease and uveitis. Preferably compositions, such as cremes and ointments, for local use on skin surfaces, eye agents, compositions for local treatment of the intestinal canal, vaginal agents, compositions for local use in the oral cavity and compositions for inhalation are produced. |
